GlassScriptPhysician profile
Anton Svetlanov
NPI 1346667599
$9,773.80
in general payments reported to CMS, 2019-2025
57 companies · $1,965 in 2025
The $1,965 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $508 · 2021: $1,162 · 2022: $1,875 · 2023: $1,991 · 2024: $2,057 · 2025: $1,965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,946 · Education: $66.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,946.36 |
| Education | $66.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,560.55 | 2021-2025 | |
| Abbvie INC. | $875.74 | 2021-2025 | Qulipta, Ubrelvy, Botox |
| Neurocrine Biosciences, INC. | $793.25 | 2019-2025 | Ingrezza, Ongentys |
| Biogen, INC. | $742.89 | 2019-2025 | Vumerity, Avonex, Plegridy |
| Teva Pharmaceuticals USA, INC. | $565.15 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Boston Scientific Corporation | $533.29 | 2022-2025 | General - Dbs |
| Amneal Pharmaceuticals LLC | $521.95 | 2021-2025 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Mdd US Operations, LLC | $468.43 | 2021-2025 | Apokyn, Xadago, Apokyn |
| Ucb, INC. | $363.94 | 2019-2025 | Briviact, Rystiggo, Nayzilam |
| Abbott Laboratories | $356.24 | 2020-2025 | Infinity |
| Acadia Pharmaceuticals INC | $274.09 | 2021-2025 | Nuplazid |
| Sk Life Science, INC. | $242.85 | 2020-2025 | |
| Argenx US, INC. | $238.60 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Kyowa Kirin, INC. | $221.18 | 2020-2023 | Nourianz |
| Janssen Pharmaceuticals, INC | $154.95 | 2021-2022 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $132.34 | 2019-2024 | Ultomiris |
| Ge Healthcare | $126.76 | 2020-2024 | |
| Lilly USA, LLC | $114.86 | 2021-2025 | Emgality, Amyvid, Reyvow |
| Medtronic, INC. | $111.65 | 2022-2024 | Percept PC Brainsense |
| Amgen INC. | $108.74 | 2019-2021 | |
| Eisai INC. | $98.85 | 2020-2024 | |
| Celgene Corporation | $92.36 | 2022-2024 | Zeposia |
| Acorda Therapeutics, INC | $83.36 | 2021-2024 | Ampyra, Inbrija |
| Otsuka America Pharmaceutical, INC. | $76.82 | 2023-2025 | Rexulti, Nuedexta |
| Lundbeck LLC | $71.96 | 2023-2025 | Vyepti, Rexulti |
| Genentech USA, INC. | $69.93 | 2023-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Emd Serono, INC. | $59.23 | 2021-2022 | |
| Grifols USA, LLC | $58.20 | 2022-2025 | Gamunex-C |
| Merz Pharmaceuticals, LLC | $51.83 | 2025 | Xeomin, Inbrija |
| Genzyme Corporation | $44.86 | 2020 | |
| Neurelis, INC. | $44.21 | 2021-2025 | Valtoco |
| Adamas Pharmaceuticals, INC. | $43.33 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $39.48 | 2020-2022 | |
| Otter Pharmaceuticals, LLC | $33.69 | 2025 | Sympazan |
| Merz North America, INC. | $29.48 | 2019 | |
| Supernus Pharmaceuticals, INC. | $28.26 | 2020-2022 | |
| Avion Pharmaceuticals | $27.18 | 2022-2023 | Dhivy |
| Exact Sciences Corporation | $23.67 | 2025 | Cologuard Collection Kit |
| Spr Therapeutics, INC | $22.17 | 2025 | Sprint Pns System |
| Pfizer INC. | $21.18 | 2025 | |
| Azurity Pharmaceuticals, INC. | $18.90 | 2025 | Horizant |
| Tg Therapeutics, INC. | $18.81 | 2025 | |
| Biohaven Pharmaceuticals, INC. | $17.49 | 2021 | |
| Banner Life Sciences, LLC | $15.60 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.00 | 2021 | |
| Allergan, INC. | $14.90 | 2022 | |
| Horizon Therapeutics Plc | $14.62 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.48 | 2022 | |
| Akcea Therapeutics, INC. | $14.40 | 2020 | |
| Currax Pharmaceuticals LLC | $14.22 | 2020 | |
| Averitas Pharma INC. | $13.77 | 2025 | Qutenza |
| Impel Pharmaceuticals INC. | $13.55 | 2023 | Trudhesa |
| Livanova USA, INC. | $13.38 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceutical Holding Company LTD. | $12.08 | 2022 | |
| Mallinckrodt Hospital Products INC. | $11.95 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $11.83 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anton Svetlanov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.